Solesence, Inc. (SLSN) Stock Price & Analysis
Solesence, Inc. (SLSN) fell 5.54% to USD 0.94 as of July 25, 2026 at 02:21 UTC, according to Nexqual real-time market data.
SLSN last closed at USD 1; the session ranged USD 0.86–1.1 on volume of 81,438 shares. Market capitalization is $66.39M, with a 52-week range of USD 0.61–4.55 (NCM). Source: Nexqual, July 25, 2026 at 02:21 UTC.
Key Statistics (as of July 25, 2026 at 02:21 UTC)
| Price | USD 0.94 |
|---|---|
| Change | ▼ 5.54% (down) |
| Previous Close | USD 1 |
| Open | USD 0.98 |
| Day Range | USD 0.86 – 1.1 |
| 52-Week Range | USD 0.61 – 4.55 |
| Volume | 81,438 shares |
| Market Cap | $66.39M |
| Exchange | NCM |
Technical Analysis (SLSN)
Nexqual's technical model rates SLSN "NEUTRAL" based on 2 bullish and 3 bearish signals across 125 daily candles, as of July 25, 2026 at 02:21 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 52.05 (neutral) |
| vs SMA50 | Below (USD 1.06) |
| MACD | -0.05 (negative) |
Analyst Ratings (SLSN)
Wall Street analysts rate SLSN "None", per Nexqual as of July 25, 2026 at 02:21 UTC.
| Consensus Rating | None |
|---|
Earnings (SLSN)
| Next Earnings Date | 2026-08-06 |
|---|
Source: Nexqual, July 25, 2026 at 02:21 UTC.
Financials & Fundamentals (SLSN)
| Total Revenue | $60.40M |
|---|---|
| Revenue Growth (YoY) | -11.40% |
| Gross Margin | +26.52% |
| Operating Margin | -3.89% |
| Profit Margin | +1.56% |
| ROE | +5.88% |
| Debt / Equity | 131.33 |
| Current Ratio | 2.08 |
| Total Cash | $573,000 |
| Total Debt | $22.28M |
| Free Cash Flow | $-3.87M |
Source: Nexqual, July 25, 2026 at 02:21 UTC.
Financial Health Score (SLSN)
Nexqual rates Solesence, Inc.'s overall financial health "Weak" across five dimensions, as of July 25, 2026 at 02:21 UTC.
| Growth | Critical — Revenue -100% YoY (annual), sharp decline |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Mixed — $573K cash vs $22M debt |
| Cash Flow | Solid — Operating cash flow $171K |
| Efficiency | Mixed — ROE 6%, ROA 1.0% |
Ownership (SLSN)
| Insider Ownership | +73.11% |
|---|---|
| Institutional Ownership | +6.25% |
| Shares Outstanding | 70.63M |
| Float | 18.32M |
| Short % of Float | +1.90% |
Source: Nexqual, July 25, 2026 at 02:21 UTC.
Leadership (SLSN)
Solesence, Inc. is led by Kevin Cureton (age 63), President, CEO & Director, per Nexqual as of July 25, 2026 at 02:21 UTC.
| President, CEO & Director | Kevin Cureton (age 63) |
|---|---|
| Chief Financial Officer | Laura Riffner (age 53) |
Major Backers & Investors (SLSN)
Notable institutional backers of Solesence, Inc. include Fidelity, Morgan Stanley, according to Nexqual as of July 25, 2026 at 02:21 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Fidelity | 0.46% |
| Morgan Stanley | 0.28% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 2.77% |
| BlackRock | 2.26% |
| Geode Capital | 0.64% |
| State Street | 0.58% |
| Northern Trust | 0.2% |
Source: Nexqual, July 25, 2026 at 02:21 UTC.
From Solesence, Inc.'s Latest SEC 10-K Filing (filed 2026-03-31)
Key Strengths & Strategy (as disclosed to the SEC)
- Solesence, Inc., a science-driven company, provides engineered materials, formulation development, and commercial manufacturing services in the United States.
- The company engages in the manufacture and supply of surface engineered zinc oxide and titanium dioxide ingredients.
- It also provides skin care formulations with mineral-based UV protection enabled by proprietary active pharmaceutical ingredients; and skin health products, such as sunscreens and daily care products.
- The company sells products in various markets, including medical diagnostics, architectural coatings, industrial coating applications, abrasion-resistant additives, and plastics additives applications.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| NGEN | NervGen Pharma Corp. | USD 1.63 | ▼ 5.23% |
| ALTI | AlTi Global, Inc. | USD 3.41 | ▲ 2.1% |
| NVEC | NVE Corporation | USD 117.55 | ▲ 35.61% |
| VECO | Veeco Instruments Inc. | USD 51.66 | ▼ 5.38% |
| ACCL | Acco Group Holdings Limited | USD 2.13 | ▼ 0.47% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 02:21 UTC. This page is informational and not investment advice.